Description
In a recent presentation, Ruth Wilcox, a mechanical engineer, emphasized the critical role of bioengineering in the development and assessment of orthopedic implants, particularly for osteoarthritis. She began by clarifying her background, stating her approach would differ from clinically trained professionals. Wilcox outlined her focus on later-stage interventions for osteoarthritis, discussing devices designed to bear loads and survive extended use in the human body, from joint replacements to regenerative therapies.
Wilcox shared key advancements in total hip replacements, attributing their success to bioengineering research that has led to improved materials and designs to mitigate wear and osteolysis. However, she pointed out the changing patient demographics, including aging individuals and increased obesity, which necessitate further research to enhance device durability and performance under higher loads.
Additionally, she provided insight into challenges like subluxation in total hip replacements, where improper loading can lead to premature device failure. Wilcox stressed the importance of leveraging computational analysis in research, allowing for quicker assessments compared to experimental tests that require long cycles to complete.
Transitioning to knee interventions, Wilcox highlighted ongoing research aimed at delaying total knee replacements through devices like osteochondral scaffolds. She noted the complexities of testing these devices due to the influence of surrounding tissues and the variability among patients.
Finally, she mentioned her work in spine bioengineering, which poses unique challenges due to its complex structure. Wilcox concluded by advocating for a systems approach to integrate the advances in digital technology across the orthopedic patient care continuum, ultimately aiming to improve patient outcomes and future implant designs.